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registration was performed. The VMAT plan was transferred 
to the pseudo-CT and dose calculation was performed using 
Pinnacle (V9.10). Pass rate of the Gamma index was used to 
evaluate the similarity of the dose distributions. The dose 
acceptance criterion was evaluated as a percentage of the 
prescribed dose applying 2 %/2 mm and 1 %/1mm criteria. 
 
Results: MRCAT was generated for six of the seven patients. 
One patients’ pelvic anatomy was not correctly recognized by 
the software model, which prohibited MRCAT reconstruction. 
Pass rates for both acceptance criteria are summarized in 
table 1. For 2%/2 mm, pass rates are high, above 97.6% for 
all analyzed structures. Even for the 1%/1 mm criterion, pass 
rates are generally above 97%. In patient 3, lower pass rates 
in PTV78, seminal vesicles and rectum are observed. For this 
patient the gamma values above one are located mainly in 
and around an air cavity in the rectum (see figure 1). MRCAT 
does not assign air density to air cavities inside the patient, 
leading to the observed dose differences. However, in the 
pelvic region it might be at least as good an approximation to 
treat air cavities as water due to the mobility of the rectal 
air during the treatment course. As seen in figure 1, gamma 
values above one are also present close to the surface of the 
patient, which is caused by differences in definition of the 
outer contour of the patient. 
 
 
 
Conclusion: Overall the pseudo-CT based dose calculations 
are very similar to the CT based calculation for prostate 
cancer patients. The MRCAT software classifies internal air 
cavities as water density leading to dose differences 
compared directly to CT. In terms of the dose precision 
observed in this study the MRCAT is able to substitute the 
standard CT simulation, but a larger cohort of patients is 
needed to validate this finding. This will also reveal whether 
bone recognition capability is sufficiently versatile for 
standard clinical use. 
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Purpose or Objective: The use of gating in tangential breast 
irradiation has shown to reduce the dose delivered to the 
heart, resulting in the possibility of decreasing heart toxicity 
in long time surviving patients. The use of gating requires to 
identify which patients could be addressed to this methodic 
by comparing planning results of gated and not-gated 
simulation CT based plans. However, the required double CT 
scan (with and without gating technology), for patients 
undergoing to left-breast tangential radiation treatment, can 
result in working overhead for RTTs executing CTs and for 
planners that have to produce two opponent plans for 
allowing final gated, or not-gated treatment decision. In this 
work a tool for deciding which patients could be selected for 
gating procedures by using only not gated CT scan is 
presented. 
 
Material and Methods: Patients addressed to left-breast 
tangential irradiation without need to irradiate supra-
clavicular nodes have been retrospectively recruited in this 
study. Both gated and not-gated simulation CT were available 
for all of them. Two series of opponent, gated and not-gated, 
treatment plans have been produced and analyzed using 
Varian™ Eclipse workstation. DVHs have been extracted from 
plans and have been analyzed in order to detect which 
dosimetrical parameters are able to predict the final 
outcome: mean heart dose in gated treatment plan. 
Maximum heart distance (MHD) has been also recorded. A 
multiple linear regression model has been used to predict the 
final outcome. 
 
Results: 100 patients have been enrolled in this study and 
200 plans on 100 gated-CT and 100 not-gated CT have been 
produced. 10 patients showed mean not-gated CT heart dose 
(MNGHD) > 5 Gy (institutional threshold for addressing the 
patient to gating), resulting in a 90% overhead in terms of 
performed gated-CTs and plans. The final model shows the 
possibility to predict mean heart dose in gated treatment 
plan with a p-value < 2.2e-16, adjusted R-squared = 0.5486, 
using not gated CT based planning and geometrical 
parameters summarized as follows: 
 
Coefficients name:  β value  P-val - Pr(>|t|) 
Intercept  0.92151  2.27e-11 
V31.5 Gy Lung Basal  -4.20188  0.000299 
Mean Basal CT Heart Dose   0.54065  1.29e-13 
Basal MHD  -0.44137  0.000748 
 
In order to easily predict which gated-CT mean heart dose 
would result if patients underwent to this scanning procedure 
a nomogram has been produced allowing the users to 
manually calculate this value without scanning the patients 
with gated CT (figure 1).  
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Conclusion: The use of gated treatment in left breast 
tangential radiotherapy can result in high quantity of 
unrequested CT scans and plans for patients not needing to 
be addressed to this kind of delivery method. Our decision 
tool is able to evaluate patients that will benefit from using 
gating technology without the need to acquire a double CT 
scan and producing a double treatment plan, so making the 
whole workflow easier and faster. 
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Purpose or Objective: The conventional radiotherapy 
technique for breast cancer with locoregional lymph nodes 
consists of half beam tangential fields for the breast, 
junctioning a 3-field AP-PA half beam block for the 
supraclavicular nodes. The AP-PA fields treat a considerable 
volume of healthy tissue to high doses, and the lack of slip 
zone makes it unsuitable for deep inspiration breathhold 
where some variation of breathhold is expected. Full 
volumetric modulated arc would lead to an unwanted low-
dose spread. We therefore investigated the improvements of 
a novel hybrid RapidArc (hRA) technique which is now 
standard in our hospital. 
 
Material and Methods: Previously contoured CT scans from 
10 patients with breast tumors including lococregional lymph 
nodes were used for planning (Eclipse, Varian Medical 
Systems). Prescription was 16 fractions of 2.67 Gy. Clinically 
treated hRA plans consisted of 2 tangential open fields with a 
2 cm cranial slip zone delivering 85% of breast dose and 3 
partial RapidArc arcs of each 80°, delivering the remaining 
dose to the breast and slipzone and full dose to the cranial 
lymph nodes. A range of organs at risk (OAR) constraints 
(from high to low dose) were set on heart, contralateral (CL) 
breast, ipsilateral (IL) and CL lung, esophagus, thyroid and 
ring structures. PTV and OAR dosimetry of hRA plans were 
compared with our old conventional technique hybrid (h)-
IMRT). hIMRT plans consisted of 3 APPA half fields, delivering 
full dose to the cranial lymph nodes, 2 tangential open half 
fields delivering 85% of breast dose and 2 tangential IMRT 
fields delivering the remaining dose to the breast and 
junction. Plans were normalized to deliver similar mean 
dose. PTV and OAR metrics were compared. 
 
Results: Compared to hIMRT, hRA provided better PTV 
coverage and OAR sparing (see Table). V107% of PTV reduced 
from 4.9% to 1.3%. Both the volumes outside the PTV 
receiving 20Gy and 40Gy were reduced significantly by hRA 
(from 2014 to 1440cm3 and from 789 to 312 cm3). hRA spared 
better the esophagus and thyroid gland. Mean lung dose and 
IL lung receiving 20Gy reduced significantly, at the expense 
of a non-significant 5% increase of V5Gy to the IL lung. 
 
 
 
Conclusion: The novel hRA technique had dosimetric 
advantages for almost all investigated OAR. hRA spared 
significantly the healthy tissue around the supraclavicular 
lymph nodes. The 2cm slip zone in the hRA plan, which is not 
possible to create when using junctioning half beams, makes 
this technique also suitable for breathhold treatment. 
 
Poster Viewing: 2: Clinical: Health economics, urology and 
brain  
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Purpose or Objective: Radiotherapy centres have the 
complex task to simultaneously improve patient outcomes 
(survival and toxicity), safety, service (such as shared 
decision making) and efficiency. To address this multi headed 
challenge, centres are forced to innovate. The objective of 
our study is to investigate how well Dutch Radiotherapy 
centres have implemented innovation within the care 
environment. Our two research questions are: 1. What is the 
annual number of treatment -, technological - and 
organisational innovations? And 2. Are there differences 
between the centres?  
 
Material and Methods: A descriptive cross-sectional study 
was conducted. Two investigators started with semi 
structured interviews in participating centres, generally with 
the head of physics and the head of the department. 
Innovations in the annual policy plans from 2011- 2013 (3 
years) were classified into 3 distinct categories based on 
literature: new or significantly improved 1) treatment, 2) 
technology, or 3) organisational processes, implemented in 
clinical routine. Incremental improvements to existing 
treatments, technologies, or organisational processes were 
not included in the results below. Centres without annual 
policy plans were asked to create their own inventory, or to 
tick listed innovations from other centres. Finally, all 
participating centres received the listed innovations from 
